Tata Consultancy Services Ltd.

Tata Consultancy Services (TCS), a leading global IT services, consulting and business solutions organization, has been designated as a leader in worldwide life sciences R&D risk-based monitoring (RBM) by global market intelligence firm, IDC, in the ‘IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment’ report.

The report evaluated eight leading IT services vendors with significant RBM expertise, across a number of capability and strategy measures such as, offering roadmap, portfolio strategy, customer base, engagement capability, pricing model, investment, growth strategy, and more.

The company was recognized as a leader for its overall capability and extensive experience working with life sciences companies across all three sections of the industry: pharmaceutical, biotech and medical devices. The report further states that TCS brings a full spectrum of strong operational service capabilities to the clinical trial space, with particular strength in data management, analytics, systems integration, and RBM-specific operational processes.